A phase 1b study of sotorasib, a specific and irreversible KRAS(G12C) inhibitor, in combination with other anticancer therapies in advanced colorectal cancer (CRC) and other solid tumors (CodeBreaK 101) Meeting Abstract
| Authors: | Hong, D. S.; Yaeger, R.; Kuboki, Y.; Masuishi, T.; Barve, M. A.; Falchook, G. S.; Govindan, R.; Sohal, D.; Kasi, P. M.; Burns, T. F.; Langer, C. J.; Puri, S.; Chan, E.; Jafarinasabian, P.; Ngarmchamnanrith, G.; Rehn, M.; Tran, Q.; Gandara, D. R.; Strickler, J. H.; Fakih, M. |
| Abstract Title: | A phase 1b study of sotorasib, a specific and irreversible KRAS(G12C) inhibitor, in combination with other anticancer therapies in advanced colorectal cancer (CRC) and other solid tumors (CodeBreaK 101) |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900210 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.TPS214 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS214 -- Meeting was conducted online as well as in person -- Source: Wos |
